CorMedix announces approximately $37M asset purchase by Heron Therapeutics

CorMedix Inc. has entered into an asset purchase agreement with Heron Therapeutics, Inc. covering substantially all of its assets. The agreement's completion is subject to closing conditions and the closing of certain customer transactions.